The pathophysiology of acute graft-versus-host disease.
Despite improvements in allogeneic stem cell transplantation, acute graft-versus-host disease (GVHD) remains a significant problem after transplantation, and it is still a major cause of post-transplant mortality. Disease progression is characterized by the differentiation of alloreactive T cells to effector cells leading to tissue damage, recruitment of additional inflammatory cell populations and further cytokine dysregulation. To make the complex process of acute GVHD more explicit, the pathophysiology of acute GVHD is often divided into three different phases. This review summarizes the mechanisms involved in the three phases of acute GVHD.
Jaksch
M
M
Division of Clinical Immunology, Karolinska Institute at Karolinska University Hospital, Huddinge, Sweden. marie.jaksch@labmed.ki.se
Mattsson
J
J
D000208:Acute Disease; D000818:Animals; D016207:Cytokines / Q000096:biosynthesis; D003602:Cytotoxicity, Immunologic; D006086:Graft vs Host Disease / Q000276:immunology / Q000503:physiopathology* / Q000517:prevention & control; D006801:Humans; D007938:Leukemia / Q000276:immunology / Q000628:therapy; D008213:Lymphocyte Activation; D033581:Stem Cell Transplantation; D013601:T-Lymphocytes / Q000276:immunology
D016207:Cytokines